TAF11B Antibody

What is TAF11 and why is it important for transcription research?

TAF11 (TATA-box binding protein Associated Factor 11) is a crucial subunit of the TFIID complex, which plays a fundamental role in RNA Polymerase II-mediated transcription. Research has shown that TAF11 interacts directly with TFIIA and TBP (TATA binding protein), functioning as a bridging factor that aids in stabilizing the TFIIA-TBP-DNA complex . This stabilization is essential for proper transcriptional initiation.

TAF11 contains a highly conserved histone fold domain and an N-terminal region that are both involved in protein-protein interactions. Studies reveal that it participates in the expression of nearly all yeast mRNAs, indicating its fundamental role in gene expression . Research demonstrates that TAF11 imparts changes to both TFIIA-DNA and TBP-DNA contacts in the context of promoter DNA . These alterations enhance the formation and stabilization of the TFIIA-TBP-DNA complex.

The functional significance of TAF11 is highlighted by evidence that mutations affecting its interaction with TFIIA can lead to growth phenotypes and transcriptional defects, making it an important target for studies on transcriptional regulation mechanisms .

What types of TAF11 antibodies are available for research purposes?

Several types of TAF11 antibodies are available for various research applications:

• Polyclonal antibodies: These antibodies, such as the Novus Biologicals NBP2-58561, are developed in rabbits against specific TAF11 recombinant proteins or peptide sequences . The polyclonal nature provides recognition of multiple epitopes, potentially increasing sensitivity but with variable specificity between lots.

• Recombinant protein antigens: Products like NBP2-55367PEP serve as blocking antigens for antibody competition assays, helping validate antibody specificity . These recombinant proteins typically contain specific amino acid sequences from TAF11, such as: KEAAAEEGELESQDVSDLTTVEREDSSLLNPAAKKLKIDTKEKKEKKQKVDEDEIQKMQILVSSFSEEQLNRYEMYRR .

• Tagged antibodies: While standard unconjugated antibodies are common, specialized research may utilize fluorophore-conjugated or enzyme-linked TAF11 antibodies for direct detection in immunofluorescence or ELISA applications.

• Monoclonal antibodies: These offer higher specificity for particular epitopes compared to polyclonals, providing more consistent results between experiments but potentially with lower sensitivity.

When selecting TAF11 antibodies, researchers should consider the specific application (Western blot, immunoprecipitation, ChIP, etc.), the epitope location, and validation data demonstrating specificity in relevant experimental systems .

How should TAF11 antibody validation be approached for reliable experimental outcomes?

Thorough validation of TAF11 antibodies is critical for ensuring experimental reliability. A comprehensive validation approach should include:

Primary Validation Methods:

• Western Blot Analysis:

  • Test the antibody on cell lysates known to express TAF11 (e.g., RT-4 and U-251 MG cell lines)

  • Verify that the antibody detects a band of the expected molecular weight

  • Include positive and negative controls (e.g., TAF11 knockdown samples)

• Blocking Peptide Competition:

  • Use recombinant TAF11 protein antigens (e.g., NBP2-55367PEP) as competitive blockers

  • Pre-incubate the antibody with excess blocking peptide

  • Confirm the disappearance of specific signals in Western blot or immunofluorescence

• Immunoprecipitation-Mass Spectrometry:

  • Perform IP with the TAF11 antibody

  • Analyze the precipitated proteins to confirm TAF11 identity

  • Verify co-precipitation of known interacting partners (e.g., other TFIID components, TFIIA, TBP)

• Cross-reactivity Testing:

  • Test the antibody against related proteins (other TAF family members)

  • Ensure it doesn't recognize structurally similar proteins, particularly those with histone fold domains

Advanced Validation Approaches:

• Multiple Antibody Comparison:

  • Use different antibodies targeting distinct epitopes of TAF11

  • Compare results to identify potential epitope-specific effects

• Genetic Knockdown Verification:

  • Test antibody on samples with TAF11 knockdown or knockout

  • Confirm signal reduction corresponding to TAF11 depletion level

• Immunofluorescence Pattern Analysis:

  • Verify that subcellular localization is consistent with the expected nuclear distribution

  • Perform co-localization studies with other nuclear or TFIID markers

Comprehensive validation should be documented and included when publishing results using the antibody, including specific catalog numbers, lot information, and dilution factors to ensure reproducibility.

What are the optimal experimental conditions for using TAF11 antibodies in coimmunoprecipitation studies?

For successful coimmunoprecipitation (Co-IP) studies using TAF11 antibodies, researchers should consider the following methodological approach based on published protocols:

Buffer Composition and Cell Preparation:

• Start with appropriate cell density (e.g., OD600 ≈ 1.0 for yeast cultures)

• Prepare protein extracts immediately to minimize degradation

• Use buffers that maintain protein-protein interactions within the TFIID complex

Optimized Co-IP Protocol:

• Pre-clear extracts with protein A-Sepharose beads (50 μl) for 1 hour at 4°C

• Couple anti-TAF11 antibodies to protein A-Sepharose beads

• Incubate protein extracts with antibody-coupled beads at room temperature for 2 hours

• Perform six extensive washes to remove non-specific interactions

• Elute bound proteins by boiling in SDS-PAGE loading buffer

• Analyze by immunoblotting with antibodies specific to potential interaction partners

Critical Parameters:

• Antibody concentration must be optimized to ensure sufficient precipitation without non-specific binding

• Salt concentration in wash buffers affects stringency—higher salt (>300mM NaCl) reduces weak or non-specific interactions

• Detergent type and concentration should be mild enough to preserve interactions but sufficient to reduce background

Result Interpretation:

• The integrity of TFIID after IP can be monitored by analyzing co-precipitated proteins such as TAF1, TAF3, TAF12, and TBP

• Comparison with control IPs (using non-specific IgG) is essential to identify specific interactions

• Reciprocal IPs (using antibodies against suspected interaction partners) can confirm biological relevance

This methodology has successfully revealed that TAF11 interacts with TFIIA through both its histone fold domain and its N-terminal region, providing insights into the structural organization of transcription pre-initiation complexes .

How can TAF11 antibodies be effectively utilized in chromatin immunoprecipitation (ChIP) experiments?

TAF11 antibodies can be strategically employed in ChIP experiments to study the genomic localization of TFIID complexes and understand TAF11's role in transcriptional regulation. A comprehensive methodological approach includes:

ChIP Protocol Optimization:

• Cross-linking:

  • Treat cells with 1% formaldehyde for 10-15 minutes at room temperature

  • Quench with 125mM glycine for 5 minutes

  • Cross-linking conditions may need adjustment based on epitope accessibility

• Chromatin Preparation:

  • Lyse cells in appropriate buffer (containing 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS)

  • Sonicate to achieve chromatin fragments of 200-500bp

  • Verify fragmentation by agarose gel electrophoresis

• Immunoprecipitation:

  • Pre-clear chromatin with protein A/G beads

  • Incubate chromatin with TAF11 antibody (3-5 μg) overnight at 4°C

  • Add protein A/G beads and incubate for 2-3 hours

  • Wash extensively with increasingly stringent buffers

• Analysis:

  • Perform qPCR with primers for known TFIID-dependent promoters

  • For genome-wide analysis, proceed with library preparation and next-generation sequencing

Experimental Design Considerations:

• Include appropriate controls:

  • Input chromatin (non-immunoprecipitated)

  • IgG control (non-specific antibody)

  • Known TAF11-bound and unbound regions

• When designing experiments, consider that nearly all Pol II-transcribed genes show dependency on TFIID components, including both TATA-containing and TATA-less genes

• Special attention should be paid to genes previously characterized as "Taf1-enriched" versus "Taf1-depleted" to see if they show differential TAF11 binding patterns

Data Integration and Analysis:

• Compare TAF11 occupancy with other TFIID components

• Correlate binding patterns with gene expression data

• Consider sequential ChIP (re-ChIP) to identify genomic regions where TAF11 co-localizes with other factors

ChIP experiments with TAF11 antibodies can provide valuable insights into how TFIID components contribute to transcriptional regulation across different gene categories and cell types.

What approaches can be used to overcome epitope masking issues in TAF11 detection?

Epitope masking is a significant challenge in TAF11 detection because it exists in multi-protein complexes where its epitopes may be obstructed. Several methodological approaches can overcome this issue:

Antibody Selection Strategies:

• Multiple Epitope Targeting:

  • Use antibodies targeting different regions of TAF11

  • Based on structural studies, consider antibodies targeting both the histone fold domain and the N-terminal region

  • Compare detection patterns to identify frequently masked epitopes

• Epitope Mapping:

  • Test antibodies against different peptide fragments of TAF11, such as the sequence available in the recombinant protein antigen (NBP2-55367PEP)

  • Identify epitopes that remain accessible when TAF11 is in complex

Sample Preparation Techniques:

• Gentle Denaturation Methods:

  • Titrate SDS concentration (0.1-0.5%) to partially unfold protein complexes

  • Use mild detergents that maintain some protein structure while exposing epitopes

  • Optimize heating conditions (37°C vs. 65°C vs. 95°C) for antigen retrieval

• Complex Disruption Methods:

  • Increase salt concentration (300-500mM NaCl) to disrupt ionic interactions

  • Add chelating agents (EDTA/EGTA) to sequester divalent cations that may stabilize protein complexes

  • Use brief sonication to partially disrupt protein complexes

Application-Specific Approaches:

When working with TAF11 as part of integrative structural biology approaches, researchers should consider that the architecture of TAF11/TAF13/TBP complexes may lead to significant epitope masking . Using complementary approaches and multiple antibodies can help overcome these limitations and provide more comprehensive data.

How can researchers resolve contradictory results between different TAF11 antibodies?

Analytical Framework for Resolving Contradictions:

• Characterize the Antibodies:

  • Identify the precise epitopes recognized by each antibody

  • Review the immunogen sequences (such as the specific peptide sequence used for NBP2-58561)

  • Determine antibody types (monoclonal vs. polyclonal) and their validation history

• Comprehensive Side-by-Side Validation:

  • Test all antibodies simultaneously under identical conditions

  • Include positive controls and TAF11-depleted negative controls

  • Use blocking peptides specific to each antibody to confirm specificity

• Biological Variables Analysis:

  • Determine if contradictions are consistent across different cell types

  • Assess whether discrepancies occur under specific cellular conditions

  • Evaluate if differences correlate with known TAF11 interactions or modifications

Methodological Resolution Approaches:

• Epitope Accessibility Investigation:

  • Map the epitopes of contradictory antibodies on the TAF11 structure

  • Test detection under various denaturing and native conditions

  • Consider the TAF11/TAF13/TBP complex architecture when interpreting results

• Orthogonal Validation:

  • Employ complementary techniques that don't rely solely on antibodies:

    • RNA interference to validate specificity of signals

    • Mass spectrometry to confirm protein presence and modifications

    • Recombinant expression systems with defined TAF11 variants

Decision Matrix for Common Contradictions:

By systematically applying these approaches, researchers can resolve contradictions and develop a more complete understanding of TAF11 biology in the context of transcriptional regulation.

How can TAF11 antibodies be used to investigate protein-protein interactions in the TFIID complex?

TAF11 antibodies provide valuable tools for dissecting the complex network of protein interactions within the TFIID complex. Several methodological strategies can be employed:

Co-Immunoprecipitation Approaches:

• Standard Co-IP:

  • Immunoprecipitate with TAF11 antibodies under non-denaturing conditions

  • Analyze co-precipitated proteins by Western blot for specific TFIID components

  • Research shows that TAF11 interacts with TFIIA and TBP, as well as other TAFs

• Sequential Co-IP:

  • First IP with TAF11 antibodies

  • Elute under mild conditions

  • Perform second IP with antibodies against suspected interaction partners

  • This approach helps identify specific subcomplexes containing TAF11

Cross-Linking Enhanced Methods:

• Chemical Cross-Linking followed by IP:

  • Treat cells with cross-linkers (e.g., DSP, formaldehyde)

  • Immunoprecipitate with TAF11 antibodies

  • Analyze cross-linked partners by mass spectrometry

  • This approach can capture transient or weak interactions

• ChIP-Sequential IP (ChIP-reIP):

  • Perform ChIP with TAF11 antibody

  • Elute complexes and perform second IP with antibody against potential partner

  • Identify genomic regions bound by both proteins

Mutational Analysis Combined with Antibody Detection:

Research has shown that two distinct regions of TAF11 are involved in interaction with TFIIA: the histone fold domain and the N-terminal region . Similar approaches can be used to map other interactions:

• Introduce specific mutations in TAF11

• Immunoprecipitate with TAF11 antibodies

• Analyze how mutations affect the co-precipitation of other factors

• This approach helps map interaction surfaces between TAF11 and its partners

Proximity-Based Detection:

• Proximity Ligation Assay (PLA):

  • Use TAF11 antibody together with antibodies against potential interacting partners

  • PLA produces fluorescent spots only when proteins are within 40nm

  • This technique allows visualization of interactions in situ

These methodological approaches provide complementary information about TAF11's interactions within the TFIID complex and can help elucidate the structural and functional organization of transcription initiation complexes.

What insights can TAF11 antibody studies provide about transcriptional regulation mechanisms?

TAF11 antibody studies can reveal critical insights into transcriptional regulation mechanisms through several sophisticated research approaches:

Structural and Functional Organization of Transcription Complexes:

• Complex Assembly Dynamics:

  • Use TAF11 antibodies to track the ordered assembly of transcription factors at promoters

  • Research has shown that TAF11 "imparts changes to both TFIIA-DNA and TBP-DNA contacts," suggesting it plays a key role in stabilizing the pre-initiation complex

  • Temporal ChIP studies can reveal the dynamics of these interactions

• Architectural Analysis:

  • Immunoprecipitate TAF11-containing complexes for structural analysis

  • Correlate structural organization with functional outcomes

  • The architecture of TAF11/TAF13/TBP complexes has been studied using integrative structural biology approaches

Regulatory Mechanisms Elucidation:

• Coactivator Functions:

  • Evidence indicates TAF11 "enhances the formation and stabilization of the TFIIA-TBP-DNA complex"

  • Use antibodies to track this stabilization effect in different promoter contexts

  • Compare stable vs. regulated promoters to determine the contribution of TAF11

• Gene-Specific Regulation:

  • Research has identified that while "nearly all genes show decreased transcription upon TFIID inactivation," there are "a small number of genes with little or no apparent expression changes upon depletion of individual Tafs"

  • TAF11 antibodies can help characterize these exceptional genes and their regulatory mechanisms

• Comparative Analysis of Promoter Types:

  • Studies found that "both TATA-containing and TATA-less genes showed near-identical responses to Taf depletion"

  • ChIP experiments with TAF11 antibodies can reveal if occupancy patterns differ despite similar functional dependencies

Methodological Framework for Mechanistic Studies:

These approaches using TAF11 antibodies can significantly advance our understanding of how TFIID contributes to transcriptional regulation in different biological contexts.

How should researchers design experiments to study TAF11 in relation to other transcription factors?

Designing robust experiments to study TAF11 in relation to other transcription factors requires careful consideration of molecular interactions, temporal dynamics, and functional consequences. A comprehensive experimental design should include:

Interaction Studies Design:

• Sequential and Reciprocal Immunoprecipitation:

  • Perform IP with TAF11 antibodies followed by Western blot for other factors

  • Conduct reciprocal IPs with antibodies against TBP, TFIIA, and other TAFs

  • Compare recovery efficiencies to determine interaction strengths

  • Research has shown that TAF11 is involved in stabilizing TFIIA-TBP-DNA complexes

• Comparative Analysis Across Conditions:

  • Design experiments comparing TAF11 interactions under:

    • Different cellular states (proliferation, differentiation, stress)

    • Various treatment conditions

    • Multiple cell or tissue types

  • Include appropriate controls for each condition

Genomic Localization Experiments:

• Comparative ChIP-seq Design:

  • Perform parallel ChIP-seq for TAF11 and other transcription factors

  • Include sequential ChIP to identify co-occupied sites

  • Design primer sets for validation that target:

    • TATA-containing promoters

    • TATA-less promoters

    • Previously identified Taf1-enriched and Taf1-depleted genes

• Temporal Analysis:

  • Design time-course experiments following stimulation

  • Collect samples at multiple timepoints to capture dynamics

  • Include synchronization protocols to study cell cycle effects

Functional Studies Design:

• Depletion-Replacement Experiments:

  • Design systems for TAF11 depletion followed by rescue with:

    • Wild-type TAF11

    • Mutant versions affecting specific interactions

    • Domain-specific deletions

  • Measure transcriptional outcomes using RNA-seq or reporter assays

• Structure-Function Analysis:

  • Design experiments targeting both the histone fold domain and N-terminal region of TAF11

  • Create chimeric proteins to test domain-specific functions

  • Use antibodies specific to each domain to track their contributions

Experimental Controls and Validations:

• Essential Controls:

  • Input samples for all IP experiments

  • IgG controls for non-specific binding

  • Knockdown/knockout validations

  • Competing peptide controls for antibody specificity

• Validation Approaches:

  • Use orthogonal methods to confirm key findings

  • Employ multiple antibodies targeting different TAF11 epitopes

  • Include biological replicates across different cell lines

By carefully designing experiments that address these considerations, researchers can generate robust data on how TAF11 functions in relation to other transcription factors in the context of the TFIID complex and broader transcriptional machinery.

What are the implications of TAF11 localization patterns detected by immunofluorescence?

TAF11 localization patterns detected by immunofluorescence can provide valuable insights into its function, regulation, and role in transcriptional processes:

Subcellular Localization Patterns and Their Significance:

• Nuclear Localization:

  • As a component of TFIID, TAF11 is expected to primarily localize to the nucleus

  • Patterns within the nucleus can reveal functional compartmentalization

  • Nuclear speckle association may indicate connections to transcriptionally active regions

• Subnuclear Distribution:

  • Punctate patterns may suggest association with transcription factories

  • Co-localization with RNA Polymerase II would support active transcriptional roles

  • Exclusion from certain nuclear regions may indicate specialized functions

• Dynamic Relocalization:

  • Changes in localization patterns upon cellular stimulation could reveal regulatory mechanisms

  • Cell cycle-dependent redistribution might indicate roles in cell cycle-regulated transcription

  • Stress-induced changes would suggest involvement in adaptive responses

Methodological Considerations for Immunofluorescence:

• Optimal Fixation Methods:

  • Compare paraformaldehyde vs. methanol fixation

  • Test mild permeabilization to preserve nuclear architecture

  • Validate antibody performance under different fixation conditions

• Co-localization Studies:

  • Pair TAF11 antibodies with markers for:

    • Other TFIID components (TBP, other TAFs)

    • RNA Polymerase II

    • Chromatin markers (active vs. repressed)

Functional Implications of Different Patterns:

Immunofluorescence studies with TAF11 antibodies, such as NBP2-58561 which has been validated for this application , can reveal important aspects of TAF11's spatial organization and functional associations within the nucleus.